Throat spray and hydroxychloroquine found to reduce risk of Covid-19 infection: Singapore study
Photo - Reuters The Straits Times The Straits Times
Using a throat spray or consuming the anti-malaria drug hydroxychloroquine has been found to reduce the risk of Covid-19 infection in healthy individuals in areas with high transmission rates.
These findings were revealed by a local study of more than 3,000 healthy young migrant workers who were quarantined in Tuas South Dormitory in May last year.
The study found that taking a povidone-iodine throat spray three times a day, or the oral drug hydroxychloroquine once daily, reduced the likelihood of getting infected by Sars-CoV-2, the virus that causes Covid-19, by over 20 percent.
Throat spray and hydroxychloroquine found to reduce risk of Covid-19 infection: Singapore study-549388 daily-sun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daily-sun.com Daily Mail and Mail on Sunday newspapers.
Throat spray, oral drug for malaria-arthritis effective in reducing spread of COVID-19: Singapore study
SECTIONS
Last Updated: Apr 25, 2021, 02:04 PM IST
Share
Synopsis
The findings were made based on a large-scale clinical trial conducted last May, involving more than 3,000 migrant workers living in Tuas South Dormitory in the Industrial District of Singapore, Channel News Asia reported.
Getty Images
During the six-week trial, workers were given a povidone-iodine throat spray, which can be bought off the counter, and oral hydroxychloroquine, which requires a prescription.
3,029,815.0
An antiseptic throat spray and an oral drug usually prescribed to treat malaria and arthritis have been found to effectively reduce the spread of COVID-19 in high-transmission settings, researchers in Singapore have found, according to a media report on Sunday.
SINGAPORE - Using a throat spray or consuming the anti-malaria drug hydroxychloroquine has been found to reduce the risk of Covid-19 infection in healthy individuals in areas with high transmission rates.
These findings were revealed by a local study of more than 3,000 healthy young migrant workers who were quarantined in Tuas South Dormitory in May last year.
The study found that taking a povidone-iodine throat spray three times a day, or the oral drug hydroxychloroquine once daily, reduced the likelihood of getting infected by Sars-CoV-2, the virus that causes Covid-19, by over 20 per cent.
The study was done by a team of clinician-scientists from the National University Health System (NUHS), led by Associate Professor Raymond Seet, a senior consultant in the division of neurology at the department of medicine in National University Hospital (NUH).
Antiseptic throat spray can reduce COVID-19 spread in high-risk settings, say Singapore researchers Toggle share menu
Advertisement
Antiseptic throat spray can reduce COVID-19 spread in high-risk settings, say Singapore researchers A large-scale clinical trial was conducted last year involving more than 3,000 migrant workers in Tuas South dormitory.
Residents stand along the corridors of a Tuas South foreign workers dormitory on Apr 19, 2020. (Photo: AFP/Roslan Rahman)
25 Apr 2021 01:32PM) Share this content
Bookmark
SINGAPORE: A type of antiseptic throat spray, as well as an oral drug usually prescribed to treat malaria and arthritis, have been found to be effective in reducing the spread of COVID-19 in high-transmission settings, said Singapore researchers on Sunday (Apr 25).